PATENT CLAIM ANALYSIS

Application Number: 16007151
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["544", "360000"]

Abstract:
Provided are compounds that target the lanthionine synthetase C-like protein 2 pathway. The compounds can be used to treat a number of conditions, including infectious disease, autoimmune disease, diabetes, and a chronic inflammatory disease.

Claim (Index 49):
The method of  claim 42 , wherein the condition is influenza infection.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 94.0
- Lexical Diversity: 1.25
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15795906', '15374556', '14662506', '13100795', '15502105']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8184063670815868
- 35 USC 102 Novelty (BERT): 0.5950685133745914
- Combined Prediction Score: 0.7960725817108872
- Mean Citation Score: 500.533792
- Max Citation Score: 649.8839
- Similarity Product: 405.9950679458857

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test